Search

Search Results

• Book

  Reducing Mortality in the Perioperative Period. 2nd ed.

  Giovanni Landoni, Laura Ruggeri, Alberto Zangrillo, editors.

  Contents:
  The Risks and Benefits of the Consensus Process
  The Process of Consensus Building
  Noninvasive Ventilation to Reduce Perioperative Mortality
  Role of Inhalational Anesthetic Agents in Reducing Perioperative Mortality
  Can Neuraxial Anesthesia Reduce Perioperative Mortality
  Role of Perioperative Hemodynamic Optimization in Reducing Perioperative Mortality
  Levosimendan to Reduce Perioperative Mortality
  Perioperative b-Blocker Therapy and Survival
  Leukocyte Depletion of Transfused Blood to Reduce Perioperative Mortality
  Reducing Perioperative Mortality with Intra-Aortic Balloon Counterpulsation (IABP)
  Selective Decontamination of the Digestive Tract
  Role of Insulin in Reducing Mortality in the Perioperative Period
  Aprotinin: Pharmacological Benefits and Safety Concerns
  Consensus Conference on Perioperative Mortality: An Update
  Liberal Transfusion Strategy in the Perioperative Period
  Remote ischaemic preconditioning
  Statins
  Tranexamic acid
  Proven mortality reduction unconfirmed in most recent works. methodological problem.

  Digital Access Springer 2017
  Get Shareable Link

  View Details
• Article

  Amelioration of bendrofluazide-induced hypokalemia by timolol.

  Hettiarachchi J, Ramsay LE, Davies DL, Fraser R, Watson WS.

  Clin Pharmacol Ther. 1977 Jul;22(1):58-62.

  The beta adrenergic blocking drug, timolol, tended to correct the hypokalemia of short-term bendrofluazide treatment in 6 healthy male subjects and although the effect was small it was significant. Timolol also reduced the rise in plasma aldosterone and urine potassium excretion following bendrofluazide and increased the urine sodium/potassium ratio. There was no evidence of a shift of potassium from the intracellular to the extracellular space.

  Digital Access Access Options
  Get Shareable Link

  PubMed